Posts

Showing posts with the label Pemetrexed Market

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

-
Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...
1 comment
Read more

15 Facts About Pemetrexed Market That Will Blow Your Mind.

-
Image
Pemetrexed Market is an anti-cancer drug that is used to treat pleural mesothelioma and non-small cell lung cancer. The Food and Drug Administration approved pemetrexed for the treatment of malignant pleural mesothelioma for the first time in 2004. Pleural mesothelioma is a cancer of the mesothelium, a thin layer of tissue that covers numerous internal organs, that can be treated with cisplatin. This drug is for patients whose condition is either unrespectable or for whom curative surgery is not an option. Pemetrexed was approved by the FDA in 2008 as a first-line treatment for metastatic non-small cell lung cancer (NSCLC) in patients with non-squamous histology when used in combination with cisplatin. The company “Eli Lilly and Company” was the first to introduce a medicinal treatment for several types of cancer. They released the “Alimta” medicine to treat cancers of the lung, liver, colorectal, stomach, breast, and other organs. Primary lung cancers, also known as carcinomas, are t...
Post a Comment
Read more